Drugs / GM-CSF vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03376477 | Sep 2019 → Jan 2024 | plasma cell myeloma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GM-CSF vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03376477 ↗ |
| Modality | Vaccine | “GM-CSF vaccine” NCT03376477 ↗ |
| Route | Other | “intra-dermal injections” NCT03376477 ↗ |